HSDT
Helius Medical Technologies Inc Class ANASDAQFINANCIAL SERVICESASSET MANAGEMENT
Key Statistics
Market Cap
$97.91M
P/E Ratio
—
EPS
$-1.77
Beta
0.91
52W High
$265.50
52W Low
$1.59
50-Day MA
$2.17
200-Day MA
$6.41
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Helius Medical Technologies Inc Class A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Fundamentals
| Revenue (TTM) | $6.02M |
| Gross Profit (TTM) | $5.52M |
| EBITDA | $-243.16M |
| Operating Margin | -4430.00% |
| Return on Equity | -27.10% |
| Return on Assets | -99.10% |
| Revenue/Share (TTM) | $0.27 |
| Book Value | $6.88 |
| Price-to-Book | 0.34 |
| Price-to-Sales (TTM) | 16.27 |
| EV/Revenue | 16.83 |
| EV/EBITDA | -0.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3340.00% |
| Shares Outstanding | $53.50M |
| Float | $40.78M |
| % Insiders | 20.59% |
| % Institutions | 28.87% |
Data last updated: 4/8/2026